Search results for "lymphoma"

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a laboratory to attack cancer cells, and...
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its next-generation targeted cancer therapy...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
VigenCell

VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?

VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
Korea-Japan 'National Actor' Taken by Lymphoma, Not a Rare Cancer

Korea-Japan 'National Actor' Taken by Lymphoma, Not a Rare Cancer

The sudden news that 'national actor' Ahn Sung-ki closed his eyes on the 5th swept Japan into a mourning atmosphere.
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...